Collaborations, Competitor News, Oncology

ASCO’s CancerLinQ® and Atropos Health Collaborate to Harness Real-World Data to Provide Point-of-Care Informatics Consult to Oncologists

ALEXANDRIA, Va. and PALO ALTO, Calif., May 3, 2022 /PRNewswire/ — ASCO’s CancerLinQ® and Atropos Health announced today a new collaboration that will provide oncology clinicians with the latest real-world evidence available to help inform personalized care and treatment of an individual patient. Atropos Health and CancerLinQ will work together to provide a “digital consult” to…

Competitor News, Oncology

Real-World Data Offers Significant Opportunities for Developing New Therapies for Hematologic Cancers

May 2, 2022C.K. Wang, MD By integrating real-world data more deeply into the process of clinical research, life sciences stakeholders can open up new possibilities for therapeutic development and the evidence-based treatment of hematologic cancers. Hematologic malignancies, including leukemia, lymphoma, and multiple myeloma, represent a relatively large proportion of newly…

AI, Collaborations, Competitor News, Oncology

LifeOmic Deploys AI Solution With xCures to Improve Cancer Research and Treatment

PrecisionOCR quickly analyzes patient records to allow xCures to extract medical data and match patients with potential treatments INDIANAPOLIS , April 28, 2022 /PRNewswire/ — LifeOmic, a software company that leverages the cloud, machine learning and mobile devices to power precision health and wellness solutions, today announced xCures as a partner. xCures, a technology platform that…

Partner and Collaborator News, Synthetic Data

Researchers receive $1.2 million NIH grant to study synthetic data use in health care

(SACRAMENTO) Three researchers from UC Davis have been awarded a $1.2 million grant over four years from the National Institutes of Health (NIH) to generate high-quality synthetic data, or data generated by a computer program. The team will use artificial intelligence and machine learning (AI/ML). The research may help physicians predict, diagnose and…

Industry News, Oncology, RWE Study

Real-World Data Confirm Lack of Standard Care for Triple-Exposed Multiple Myeloma

Sucharita Mistry, PhD Real-world data confirm that there is no standard approach for treating patients with triple-class-exposed relapsed/refractory multiple myeloma (RRMM), and these patients continue to have poor outcomes.  Researchers found high variability in treatment regimens for triple-exposed RRMM patients. In addition, these patients had poor overall survival (OS) and…

Collaborations, Competitor News, Data Partnership

CENTOGENE and Takeda Extend Market Access and Expansion Partnership to Advance Patient Care Globally

April 28, 2022 06:30 ET | Source: Centogene NV Accelerating the path from diagnosis to available treatments for rare metabolic and rare neurodegenerative diseases CENTOGENE and Takeda extend contract to continue providing access to genetic testing for patients with rare metabolic and rare neurodegenerative diseases The global market access and expansion partnership…

Collaborations, Competitor News, Data Partnership, International, Middle East, RWE Study

Development and Experience with Cancer Risk Prediction Models Using Federated Databases and Electronic Health Records

ABSTRACT Early diagnosis is critical to improving survival rates of lethal cancers, such as pancreatic duct adenocarcinoma (PDAC). However, there are no reliable screening test for these cancers. In this chapter, we present potential methods for predicting early, evolving cancers by leveraging readily available electronic health record (EHR) data and…

Competitor News, RWE Study

Verana Health to Present Machine Learning and Geographic Atrophy Research at ARVO 2022 Annual Meeting

Research developed using Ophthalmology Qdata™, quality real-world data stemming from the American Academy of Ophthalmology IRIS® Registry SAN FRANCISCO, April 28, 2022 /PRNewswire/ — Verana Health®—a digital health data company elevating quality in real-world data—today announced three abstracts are to be presented at the Association for Research in Vision and Ophthalmology’s (ARVO) 2022…